Drugs / EN3270
last change Jul 2008 re-read 3 minutes ago

EN3270

Developed for
chronic pain syndrome
Investigated by
Durect

Trials 1

200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00485225 Jun 2007 → Apr 2008 chronic pain syndrome Durect Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as EN3270 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00485225 ↗
Route Other “Transdermal patch (EN3270) - Titration 1” NCT00485225 ↗